1st Quarter - Report

AMERICAN SOCIETY OF ANESTHESIOLOGISTS for AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Firm
Client
Income
—
Expenses
$210,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

No lobbying activity in this issue area in Q1 2011.

LobbyistCovered position, as disclosed
HARVEY E AMOE —
TRACI BONE New —
MANUEL BONILLA —
JASON BYRD —
MICHELLE MATHY —
SHARON MERRICK —
RONALD SZABAT —

Contacted: Defense, Dept of (DOD); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Drug Enforcement Administration (DEA); Occupational Safety & Health Administration (OSHA); Federal Trade Commission (FTC); Executive Office of the President (EOP); Justice, Dept of (DOJ); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R. 3590 Patient Protection and Affordable Care Act, Pub. Law No: 111-148 (PPACA); H.R. 451, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation National All Schedules Prescription Electronic Reporting Reauthorization Act H.R. 4872, The Health Care and Education Affordability Reconciliation Act of 2010 H.R. 5808, To amend the Patient Protection and Affordable Care Act to establish a public health insurance option PPACA Nondiscrimination language regarding paraprofessionals H.R. 756, National Pain Care Policy Act, S.660, National Pain Care Policy Act DEA Scheduling Propofol Comparative Effectiveness Research Hospital Acquired Infections HITECH Implemenation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies Physician Antitrust Relief Physician Workforce Issues Medical Liability Reform; H.R. 5, HEALTH Act of 2011 FDA Safe Use Initiative S. 296, Preserving Access to Life-saving Medications Act, drug shortages Pain Management Pediatric Anesthesia FDA Operating Room Fires FDA ACTION Initiative FDA Propofol Shortage FDA Sentinel Prescription Drug User Fee Act Deep sedation NASPER Funding; controlled substance abuse, misuse and diversion Required Physician Supervision of Nurse Anesthetists, Nurse error rates State Exchanges pursuant to PPACA Patient Safety Initiatives FDA SEDASYS FDA Sedation Products Request for Assistance

LobbyistCovered position, as disclosed
HARVEY E AMOE —
TRACI BONE New —
MANUEL BONILLA —
JASON BYRD —
MICHELLE MATHY —
SHARON MERRICK —
RONALD SZABAT —

Contacted: Food & Drug Administration (FDA); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Occupational Safety & Health Administration (OSHA); Federal Trade Commission (FTC); Office of Management & Budget (OMB); Defense, Dept of (DOD); Justice, Dept of (DOJ); SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3590 (112th), H.R. 756 (112th), H.R. 4872 (112th), H.R. 451 (112th), H.R. 5808 (112th), S. 660 (112th), H.R. 5 (112th), S. 296 (112th)

Medicare/Medicaid MMM

H.R. 1044, Medicare Access to Rural Anesthesiology Act: Rural Pass Through Part B Medicare Physician's Fee Schedule: Implementation of Medicare Anesthesiology Teaching Funding Restoration Act 2011 Medicare Physician Fee Schedule proposed and final rules Medicare Reform, Payment Issues: Medicare Sustainable Growth Rate Physician Payment Update Scope of Practice Bundled payments CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services CMS IPPS Medicare Payment CMS Physician Resource Use Reports CMS ICD-10 CMS Hospital Outpatient Payment Proposed Rule CMS Hospital Acquired Conditions CMS Value-Based purchasing CMS Recovery Audit Contractors Program Conditions of Participation - Anesthesia services, opt-outs, supervision S. 454, Strengthening Program Integrity in Health Care Act of 2011 S. 668, Health Care Bureaucrats Elimination Act Physician Quality Report System, Quality, Sec. 3007 Quality Modifier CMS E-Prescribing CMS Practicing Physicians' Advisory Council Nominations Medicaid Expansion: Provider payment levels Medicare Expansion, Ages 55-64 Independent Payment Advisory Board (IPAB Repeal) Balance billing MedPAC nominations CMS Handoffs Accountable Care Organizations Misvalued codes Historical Medicare payment undervaluation for anesthesiology services (33% problem) Medical loss ratios Anesthesia Conversion Factor Public Plan - Negotiated Provider Payment Rates Perioperative Home Model

LobbyistCovered position, as disclosed
HARVEY E AMOE —
TRACI BONE New —
MANUEL BONILLA —
JASON BYRD —
MICHELLE MATHY —
SHARON MERRICK —
RONALD SZABAT —

Contacted: Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); SENATE; Government Accountability Office (GAO); Defense, Dept of (DOD); Centers For Medicare and Medicaid Services (CMS); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Occupational Safety & Health Administration (OSHA); Office of Management & Budget (OMB)

Bills named: S. 668 (112th), S. 454 (112th), H.R. 1044 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.